Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
20.01
-0.22 (-1.09%)
At close: Nov 17, 2026

SHA:688739 Revenue

Liaoning Chengda Biotechnology had revenue of 365.98M CNY in the quarter ending September 30, 2026, a decrease of -5.94%. This brings the company's total for the last twelve months to 1.34B, down -8.97% year-over-year. In the year 2025, Liaoning Chengda Biotechnology had annual revenue of 1.39B, down -17.06%. That makes Liaoning Chengda Biotechnology the 17,491st largest company in the world by revenue and 3,182nd in China.

Revenue (ttm)
1.34B
Revenue Growth
-8.97%
P/S Ratio
6.21
Revenue / Employee
843.94K
Employees
1,585
Market Cap
8.22B

Revenue Chart

Revenue by Geography

  • China 1.15B 82.6%
  • Overseas 241.92M 17.4%
Fiscal year ended Dec 31, 2025 See the full SHA:688739 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.39B-285.95M-17.06%
Dec 31, 20241.68B-73.86M-4.22%
Dec 31, 20231.75B-64.90M-3.58%
Dec 31, 20221.81B-273.04M-13.08%
Dec 31, 20212.09B92.47M4.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.